Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radha Rajasingham
David R Boulware

Showing results (61-70 of 435) with videos related to

Pageof 44
Sort By:
Journal of Travel Medicine|February 5, 2009
The Nepalese shepherdMrinal M Patnaik, Radha Rajasingham, Alaka Deshpande, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2023
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infectionElizabeth S Aby, Radha Rajasingham, Eva A Enns, et al.
Urology|March 31, 2018
Successful Conservative Management of Bilateral Renal MucormycosisBenjamin M Marsh, Radha Rajasingham, Sherif H Tawfic, et al.
Medical Mycology|November 6, 2019
Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for managementKatelyn A Pastick, Elizabeth Nalintya, Lillian Tugume, et al.
Journal of Clinical Microbiology|June 2, 2021
Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal MeningitisKiiza Kandole Tadeo, Audrey Nimwesiga, Richard Kwizera, et al.
Wellcome Open Research|July 21, 2018
Can improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in UgandaFiona V Cresswell, Ananta S Bangdiwala, Nathan C Bahr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2022
Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile InfectionElizabeth S Aby, Byron P Vaughn, Eva A Enns, et al.
Open Forum Infectious Diseases|February 24, 2021
Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19David Seftel, David R Boulware
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19David R Boulware, Mahsa Abassi
Mediators of Inflammation|November 12, 2020
Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal MeningitisElizabeth C Okafor, Katherine H Hullsiek, Darlisha A Williams, et al.
Pageof 44

Showing results (61-70 of 435) with videos related to

Sort By:
Pageof 44
Journal of Travel Medicine|February 5, 2009
The Nepalese shepherdMrinal M Patnaik, Radha Rajasingham, Alaka Deshpande, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2023
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infectionElizabeth S Aby, Radha Rajasingham, Eva A Enns, et al.
Urology|March 31, 2018
Successful Conservative Management of Bilateral Renal MucormycosisBenjamin M Marsh, Radha Rajasingham, Sherif H Tawfic, et al.
Medical Mycology|November 6, 2019
Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for managementKatelyn A Pastick, Elizabeth Nalintya, Lillian Tugume, et al.
Journal of Clinical Microbiology|June 2, 2021
Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal MeningitisKiiza Kandole Tadeo, Audrey Nimwesiga, Richard Kwizera, et al.
Wellcome Open Research|July 21, 2018
Can improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in UgandaFiona V Cresswell, Ananta S Bangdiwala, Nathan C Bahr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2022
Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile InfectionElizabeth S Aby, Byron P Vaughn, Eva A Enns, et al.
Open Forum Infectious Diseases|February 24, 2021
Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19David Seftel, David R Boulware
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19David R Boulware, Mahsa Abassi
Mediators of Inflammation|November 12, 2020
Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal MeningitisElizabeth C Okafor, Katherine H Hullsiek, Darlisha A Williams, et al.
Pageof 44